Hemophilia A is a rare bleeding disorder caused by mutations in the F8 gene, leading to insufficient clotting factor VIII (FVIII) in the bloodstream. FVIII is crucial for normal blood clotting, and the severity of hemophilia is determined by its deficiency. Lower levels of FVIII increase the likelihood of bleeding, potentially resulting in significant health complications.
Hemophilia A occurs in about one in every 5,000-10,000 male births worldwide. Individuals with hemophilia A face heightened risks of spontaneous bleeding and bleeding post injuries or surgical procedures. This lifelong condition requires continuous monitoring and treatment.
For comments and feedback contact: editorial@rttnews.com
May 22, 2026 14:46 ET Minutes of the latest Fed policy session was the highlight of the week along with survey data on the U.S. housing market. In Europe, survey data signaled the trends in the euro area private sector. Further, consumer price inflation data from the U.K. was in focus. In Asia, various economic indicators from China drew attention to the health of the economy.